VGX-1027(Git-27) structure
|
Common Name | VGX-1027(Git-27) | ||
|---|---|---|---|---|
| CAS Number | 6501-72-0 | Molecular Weight | 205.210 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 381.4±34.0 °C at 760 mmHg | |
| Molecular Formula | C11H11NO3 | Melting Point | 159 °C | |
| MSDS | N/A | Flash Point | 184.5±25.7 °C | |
Use of VGX-1027(Git-27)VGX-1027(GIT27) is an isoxazole compound that exhibits various immunomodulatory properties; reduce the secretion of IL-1beta, TNF-alpha and IL-10 from purified murine macrophages.IC50 value: Target: immunomodulatorAdministration of VGX-1027 to NOD mice with spontaneous or accelerated forms of diabetes induced either by injection of cyclophosphamide or by transfer of spleen cells from acutely diabetic syngeneic donors markedly reduced the cumulative incidence of diabetes and insulitis. In addition, VGX-1027 given either i.p. or p.o. to CBA/H mice made diabetic with multiple low doses of streptozotocin successfully counteracted the development of destructive insulitis and hyperglycemia [1]. VGX-1027 appeared to spare T cell function as it was unable to modify the proliferation and/or secretion of IL-2, IFN-gamma and IL-4 induced in purified murine CD4+ T cells from stimulation with either CD3+CD28 or ConA [2]. VGX-1027 inhibited both proliferation of enterobacterial antigen-reactive CD4+CD25- T cells in vitro and the development of clinical and histological signs of colitis in vivo [3]. |
This table lists Chinese names, IUPAC names and various aliases of this chemical substance.
| Name | 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid |
|---|---|
| Synonym | More Synonyms |
This table contains bioactivity, target information and biological‑assay experimental data of this compound.
| Description | VGX-1027(GIT27) is an isoxazole compound that exhibits various immunomodulatory properties; reduce the secretion of IL-1beta, TNF-alpha and IL-10 from purified murine macrophages.IC50 value: Target: immunomodulatorAdministration of VGX-1027 to NOD mice with spontaneous or accelerated forms of diabetes induced either by injection of cyclophosphamide or by transfer of spleen cells from acutely diabetic syngeneic donors markedly reduced the cumulative incidence of diabetes and insulitis. In addition, VGX-1027 given either i.p. or p.o. to CBA/H mice made diabetic with multiple low doses of streptozotocin successfully counteracted the development of destructive insulitis and hyperglycemia [1]. VGX-1027 appeared to spare T cell function as it was unable to modify the proliferation and/or secretion of IL-2, IFN-gamma and IL-4 induced in purified murine CD4+ T cells from stimulation with either CD3+CD28 or ConA [2]. VGX-1027 inhibited both proliferation of enterobacterial antigen-reactive CD4+CD25- T cells in vitro and the development of clinical and histological signs of colitis in vivo [3]. |
|---|---|
| Related Catalog | |
| References |
This table shows physicochemical parameters including melting point, boiling point, density, solubility and optical rotation. Missing data is marked as N/A.
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 381.4±34.0 °C at 760 mmHg |
| Melting Point | 159 °C |
| Molecular Formula | C11H11NO3 |
| Molecular Weight | 205.210 |
| Flash Point | 184.5±25.7 °C |
| Exact Mass | 205.073898 |
| PSA | 58.89000 |
| LogP | 1.16 |
| Vapour Pressure | 0.0±0.9 mmHg at 25°C |
| Index of Refraction | 1.601 |
| InChIKey | MUFJHYRCIHHATF-UHFFFAOYSA-N |
| SMILES | O=C(O)CC1CC(c2ccccc2)=NO1 |
This table presents publicly reported synthetic routes, reaction conditions, reactants and product information of the compound.
|
~%
VGX-1027(Git-27) CAS#:6501-72-0 |
| Literature: GANIAL IMMUNOTHERAPEUTICS INC. Patent: WO2006/97273 A1, 2006 ; Location in patent: Page/Page column 13 ; |
|
~%
VGX-1027(Git-27) CAS#:6501-72-0 |
| Literature: Eichinger, Karl; Wokurek, Michael; Zauner, Bernd; Rostami, Mohammad Reza Synthetic Communications, 1997 , vol. 27, # 16 p. 2733 - 2742 |
|
~%
VGX-1027(Git-27) CAS#:6501-72-0 |
| Literature: Stosic-Grujicic, Stanislava; Cvetkovic, Ivana; Mangano, Katia; Fresta, Massimo; Maksimovic-Ivanic, Danijela; Harhaji, Ljubica; Popadic, Dusan; Momcilovic, Miljana; Miljkovic, Djordje; Kim, Joseph; Al Abed, Yousef; Nicoletti, Ferdinando Journal of Pharmacology and Experimental Therapeutics, 2007 , vol. 320, # 3 p. 1038 - 1049 |
This table lists upstream starting materials and downstream derivative products related to this chemical.
| Precursor 3 | |
|---|---|
| DownStream 0 | |
This table contains target information, in‑vitro & in‑vivo assay data for this compound.
This table collects all English aliases, systematic names and CAS‑related synonyms of the compound.
| GIT 27 |
| 3-phenyl-4,5-dihydro-5-isoxazoleacetic acid |
| 4,5-DIHYDRO-3-PHENYL-5-ISOXAZOLEACETIC ACID |
| (3-Phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid |
| VGX-1027 |
This section contains frequently‑asked‑questions about this compound, including basic parameters, properties, storage conditions and corresponding answers.
| Q: What is the SMILES notation of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid? |
| A: SMILES notation of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid is O=C(O)CC1CC(c2ccccc2)=NO1. |
| Q: What is the Chinese name of 6501-72-0? |
| A: Chinese name of 6501-72-0 is VGX-1027. |
| Q: What is the molecular formula of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid? |
| A: Molecular formula of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid is C11H11NO3. |
| Q: What is the LogP of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid? |
| A: LogP of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid is 1.16. |
| Q: What is the molecular weight of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid? |
| A: Molecular weight of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid is 205.210. |
| Q: What is the CAS number of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid? |
| A: CAS number of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid is 6501-72-0. |
| Q: What is the boiling point of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid? |
| A: Boiling point of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid is 381.4±34.0 °C at 760 mmHg. |
| Q: What is the InChIKey of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid? |
| A: InChIKey of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid is MUFJHYRCIHHATF-UHFFFAOYSA-N. |
| Q: What are the upstream materials of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid? |
| A: Related upstream materials(CAS) of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid: 625-38-7;613-91-2;698-16-8. |
| Q: What English synonyms does 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid have? |
| A: English synonyms of 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid: GIT 27, 3-phenyl-4,5-dihydro-5-isoxazoleacetic acid, 4,5-DIHYDRO-3-PHENYL-5-ISOXAZOLEACETIC ACID, (3-Phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid, VGX-1027. |
This table lists manufacturers and suppliers of this compound, including vendor names and product supply reference information.
| Shanghai Nianxing Industrial Co., Ltd |
| Dayang Chem (Hangzhou) Co., Ltd. |